Innocan Pharma Corporation: Innocan Pharma Reports Success in a Pre-Clinical Trial of a Liposomal-CBD Injection on a Paralyzed Goat

HERZLIYA, Israel and CALGARY, Alberta, May 8, 2023 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a leading pharmaceutical and

Related Keywords

Canada ,Germany ,Herzliya ,Tel Aviv ,Israel ,Canadian ,Eva Reuter ,Innocan Pharma ,Iris Bincovich ,Prnewswire Innocan Pharma Corporation ,Bi Sky Global Ltd ,Innocan Pharma Corporation ,Company Or Innocan ,Pharma Corporation ,Central Nervous System ,Consumer Wellness ,Joint Venture ,Gefallene Big Techs ,Innocan ,Dharma ,Corporation ,Reports ,Success ,Linical ,Trial ,Liposomal ,Injection ,Paralyzed ,Boat ,